Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Julphar
AstraZeneca
Cerilliant
McKesson
Fuji
Moodys
Boehringer Ingelheim

Generated: July 19, 2018

DrugPatentWatch Database Preview

Masoprocol - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for masoprocol and what is the scope of masoprocol patent protection?

Masoprocol
is the generic ingredient in one branded drug marketed by Univ Az Cancer Ctr and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for masoprocol.
Summary for masoprocol
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 34
Clinical Trials: 1
Patent Applications: 6,117
DailyMed Link:masoprocol at DailyMed
Medical Subject Heading (MeSH) Categories for masoprocol
Synonyms for masoprocol
(R*,S*)-4,4'-(2,3-Dimethylbutane-1,4-diyl)bispyrocatechol
1,2-Benzenediol, 4,4'-((2R,3S)-2,3-dimethyl-1,4-butanediyl)bis-, rel-
1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-, (R*,S*)-
27686-84-6
334707-72-1
3B1-003853
4-[(2r,3s)-3-[(3,4-Dihydroxyphenyl)methyl]-2-Methylbutyl]benzene-1,2-Diol
4-[(2R,3S)-4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]benzene-1,2-diol
4-[(2R,3S)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
4-[(2S,3R)-3-[(3,4-dihydroxyphenyl)methyl]-2-methylbutyl]benzene-1,2-diol
4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
4,4'-((2R,3S)-2,3-Dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
4,4'-((2R,3S)-rel-2,3-Dimethylbutane-1,4-diyl)bis(benzene-1,2-diol)
4,4'-[(2R,3S)-2,3-Dimethyl-1,4-butanediyl]biscatechol
686B846
741285-10-9
7BO8G1BYQU
AC1L2G35
AC1Q7ACC
Actinex
Actinex (TN)
AJ-08347
AK129790
AKOS016014015
API0001379
AX8137243
AX8267578
BDBM22372
BIDD:ER0127
C18H22O4
CAS-27686-84-6
CCG-204959
CHEBI:73468
CHEMBL313972
CHX 100
CHX-100
D04862
D0S8BG
DB00179
DR001224
DSSTox_CID_25178
DSSTox_GSID_45178
DSSTox_RID_80726
DTXSID5045178
EINECS 248-606-6
EMD 55900
erythro-nordihydroguaiaretic acid
EU-0100877
HMS3262P15
INSM-18
KB-239312
Lopac-N-5023
Lopac0_000877
LP00877
LS-174190
Masoprocol (Nordihydroguaiaretic)
Masoprocol (USAN/INN)
Masoprocol [USAN:INN]
Masoprocolum
Masoprocolum [INN-Latin]
meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane
meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane
meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)
meso-4,4'-(2,3-Dimethyltetrameth-ylene)dipyrocatechol
meso-4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol
meso-beta,gamma-dimethyl-alpha,delta-bis(3,4-dihydroxyphenyl)butan
meso-NDGA
meso-Nordihydroguaiaretic acid
mesonordihydroguaiaretic acid
N 5023
NCGC00015741-01
NCGC00015741-02
NCGC00015741-03
NCGC00015741-06
NCGC00015741-07
NCGC00094201-01
NCGC00094201-02
NCGC00094201-03
NCGC00094201-04
NCGC00094201-05
NCGC00261562-01
Nordihydroguaiaretic acid (meso-form)
nordihydroguaiaretic acid (ndga)
Nordihydroguaiaretic acid from Larrea divaricata (creosote bush)
Nordihydroguaiaretsaure
OR111534
OR251848
SCHEMBL3818
SR-01000076028
SR-01000076028-1
TNP00263
Tox21_110210
Tox21_500877
UNII-7BO8G1BYQU
Z-3136
ZB000699
ZINC12342

US Patents and Regulatory Information for masoprocol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Dow
Chubb
McKinsey
Colorcon
Citi
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.